Literature DB >> 21956692

Novel random peptide libraries displayed on AAV serotype 9 for selection of endothelial cell-directed gene transfer vectors.

K Varadi1, S Michelfelder, T Korff, M Hecker, M Trepel, H A Katus, J A Kleinschmidt, O J Müller.   

Abstract

We have demonstrated the potential of random peptide libraries displayed on adeno-associated virus (AAV)2 to select for AAV2 vectors with improved efficiency for cell type-directed gene transfer. AAV9, however, may have advantages over AAV2 because of a lower prevalence of neutralizing antibodies in humans and more efficient gene transfer in vivo. Here we provide evidence that random peptide libraries can be displayed on AAV9 and can be utilized to select for AAV9 capsids redirected to the cell type of interest. We generated an AAV9 peptide display library, which ensures that the displayed peptides correspond to the packaged genomes and performed four consecutive selection rounds on human coronary artery endothelial cells in vitro. This screening yielded AAV9 library capsids with distinct peptide motifs enabling up to 40-fold improved transduction efficiencies compared with wild-type (wt) AAV9 vectors. Incorporating sequences selected from AAV9 libraries into AAV2 capsids could not increase transduction as efficiently as in the AAV9 context. To analyze the potential on endothelial cells in the intact natural vascular context, human umbilical veins were incubated with the selected AAV in situ and endothelial cells were isolated. Fluorescence-activated cell sorting analysis revealed a 200-fold improved transduction efficiency compared with wt AAV9 vectors. Furthermore, AAV9 vectors with targeting sequences selected from AAV9 libraries revealed an increased transduction efficiency in the presence of human intravenous immunoglobulins, suggesting a reduced immunogenicity. We conclude that our novel AAV9 peptide library is functional and can be used to select for vectors for future preclinical and clinical gene transfer applications.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21956692     DOI: 10.1038/gt.2011.143

Source DB:  PubMed          Journal:  Gene Ther        ISSN: 0969-7128            Impact factor:   5.250


  40 in total

1.  Intranasal vaccination with AAV5 and 9 vectors against human papillomavirus type 16 in rhesus macaques.

Authors:  Karen Nieto; Christiane Stahl-Hennig; Barbara Leuchs; Martin Müller; Lutz Gissmann; Jürgen A Kleinschmidt
Journal:  Hum Gene Ther       Date:  2012-04-18       Impact factor: 5.695

Review 2.  E Pluribus Unum: 50 Years of Research, Millions of Viruses, and One Goal--Tailored Acceleration of AAV Evolution.

Authors:  Dirk Grimm; Sergei Zolotukhin
Journal:  Mol Ther       Date:  2015-09-21       Impact factor: 11.454

3.  Inhibition of the NF-κB pathway by R65 ribozyme gene via adeno-associated virus serotype 9 ameliorated oxidized LDL induced human umbilical vein endothelial cell injury.

Authors:  Hui Zhai; Qing-Jie Chen; Xiao-Ming Gao; Yi-Tong Ma; Bang-Dang Chen; Zi-Xiang Yu; Xiao-Mei Li; Fen Liu; Yang Xiang; Jia Xie; Yi-Ning Yang
Journal:  Int J Clin Exp Pathol       Date:  2015-09-01

4.  Trafficking of adeno-associated virus vectors across a model of the blood-brain barrier; a comparative study of transcytosis and transduction using primary human brain endothelial cells.

Authors:  Steven F Merkel; Allison M Andrews; Evan M Lutton; Dakai Mu; Eloise Hudry; Bradley T Hyman; Casey A Maguire; Servio H Ramirez
Journal:  J Neurochem       Date:  2016-12-15       Impact factor: 5.372

Review 5.  Gene therapy for neurological disorders: progress and prospects.

Authors:  Benjamin E Deverman; Bernard M Ravina; Krystof S Bankiewicz; Steven M Paul; Dinah W Y Sah
Journal:  Nat Rev Drug Discov       Date:  2018-08-10       Impact factor: 84.694

6.  Integrin-YAP/TAZ-JNK cascade mediates atheroprotective effect of unidirectional shear flow.

Authors:  Li Wang; Jiang-Yun Luo; Bochuan Li; Xiao Yu Tian; Li-Jing Chen; Yuhong Huang; Jian Liu; Dan Deng; Chi Wai Lau; Song Wan; Ding Ai; King-Lun Kingston Mak; Ka Kui Tong; Kin Ming Kwan; Nanping Wang; Jeng-Jiann Chiu; Yi Zhu; Yu Huang
Journal:  Nature       Date:  2016-12-07       Impact factor: 49.962

Review 7.  Engineering adeno-associated viruses for clinical gene therapy.

Authors:  Melissa A Kotterman; David V Schaffer
Journal:  Nat Rev Genet       Date:  2014-05-20       Impact factor: 53.242

Review 8.  Gene therapy for the nervous system: challenges and new strategies.

Authors:  Casey A Maguire; Servio H Ramirez; Steven F Merkel; Miguel Sena-Esteves; Xandra O Breakefield
Journal:  Neurotherapeutics       Date:  2014-10       Impact factor: 7.620

9.  Tropism-modified AAV vectors overcome barriers to successful cutaneous therapy.

Authors:  Jessica Sallach; Giovanni Di Pasquale; Fernando Larcher; Nadine Niehoff; Matthias Rübsam; Anke Huber; Jay Chiorini; David Almarza; Sabine A Eming; Hikmet Ulus; Stephen Nishimura; Ulrich T Hacker; Michael Hallek; Carien M Niessen; Hildegard Büning
Journal:  Mol Ther       Date:  2014-01-28       Impact factor: 11.454

10.  Stage-dependent remodeling of projections to motor cortex in ALS mouse model revealed by a new variant retrograde-AAV9.

Authors:  Barbara Commisso; Lingjun Ding; Karl Varadi; Martin Gorges; David Bayer; Tobias M Boeckers; Albert C Ludolph; Jan Kassubek; Oliver J Müller; Francesco Roselli
Journal:  Elife       Date:  2018-08-23       Impact factor: 8.140

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.